Bone pain in thalassaemia: Assessment of DEXA and MRI findings

Journal of Pediatric Endocrinology and Metabolism

Volumn 11, Issue SUPPL. 3, 1998, Pages 779-784

  Angastiniotis, M ^a   Pavlides, N ^a   Aristidou, K ^b   Kanakas, A ^c   Yerakaris, M ^d   Eracleous, E ^d   Posporis, Th ^d  

^a Thalassaemia Centre   (Cyprus)

^b Makarios III Hospital   (Cyprus)

^c X Ray and Bone Centre   (Cyprus)

^d Agios Therissos MRI Centre   (Cyprus)

Author keywords

DEXA; MRI; Osteoporosis; Thalassaemia

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM ANTAGONIST; HYDROXYUREA; VITAMIN D;

ADOLESCENT; ADULT; BETA THALASSEMIA; BLOOD TRANSFUSION; BONE DENSITY; BONE MARROW; BONE PAIN; CONFERENCE PAPER; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; HYPERPLASIA; HYPOGONADISM; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; SCHOOL CHILD;

ADULT; AGING; BETA-THALASSEMIA; BLOOD TRANSFUSION; BONE AND BONES; BONE DENSITY; BONE MARROW; DENSITOMETRY, X-RAY; FEMALE; HOMOZYGOTE; HUMANS; HYDROXYUREA; HYPERPLASIA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PAIN;

EID: 0032424946     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Giardina P. Osteoporosis in thalassaemia. TIP News 1994; 12: 11, and
2. Giardina P. Osteoporosis in thalassaemia. TIP News 1995; 13:11-12.
3. Jensen C, Tuck SM, Yardumian A, Agnew JE, Koneru S, Hoffbrand AV, Prescott E, Wonke B. Osteoporosis in thalassaemia major. Presentation at the 6th International Conference on Thalassaemia and the Haemoglobinopathies, Malta, April 1997. Abst 253.
4. Pootrakool P, Hungsprenges S, Fucharoen S, Baylink D, Thompson E, English E, Lee M, Burnell J, Finch C. Relation between erythropoiesis and bone marrow metabolism in thalassaemia. N Engl J Med 1981; 304: 1470-1473.
5. Anapliotou ML, Kastanias IT, Psara P, Evangelou E, Liparaki M, Demetriou P. The contribution of hypogonadism to the development of Osteoporosis in thalassaemia major: new therapeutic approaches. Clin Endocrinol 1995; 42: 279-287.
6. De Sanctis V, Ruggiero L. Hormonal treatment and bone densitometry in thalassaemic patients with delayed puberty and hypogonadism. 6th International Conference on Thalassaemia and Haemoglobinopathies, Malta, April 1997. Abst 266.
7. Rioja L, Girot R, Garabedian M, Cournot Witmer G. Bone disease in children with homozygous β thalassaemia. Bone Mineral 1990; 8: 69-86.
8. Raisz LG. Therapeutic options for the patient with Osteoporosis. Endocrinologist 1991; 11-17.
9. Porter BA, Shields AF, Olson DO. Magnetic resonance imaging of bone marrow disorders. Radiol Clin N Am 1986; 24: 269.
10. Lewis S, Wainscoat JS, Moore NR, Golding SJ. Magnetic resonance imaging in myelodysplastic syndromes. Br J Radiol 1995; 68: 121-127.
11. Mankad VN, Williams JP, Harpen MD, Manci E, Longenecker G, Moore B, Shah A, Yang YM, Brogdon BG. Magnetic resonance imaging of bone marrow in sickle cell disease: Clinical, hematologic and pathological correlations. Blood 1990; 75: 274.
12. Wehrli FW, Ford JC, Haddad JG. Osteoporosis: Clinical assessment with quantitative MR imaging in diagnosis. Radiology 1995; 196:631-641.
13. Levine L, Sheth SS, Ruzal-Schapiro C, Abramson S, Piomelli S, Berdon WE. MRI marrow observations in thalassaemia: the effects of the primary disease, transfusion therapy and chelation. Pediatr Radiol 1995; 25: 607-613.